FFNT Stock Overview
Owns and manages licensed cannabis facilities in state-licensed markets in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
4Front Ventures Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.08 |
| 52 Week High | CA$0.40 |
| 52 Week Low | CA$0.07 |
| Beta | 1.12 |
| 11 Month Change | -40.74% |
| 3 Month Change | -36.00% |
| 1 Year Change | -36.00% |
| 33 Year Change | -94.20% |
| 5 Year Change | -88.73% |
| Change since IPO | -92.86% |
Recent News & Updates
Recent updates
Investors Give 4Front Ventures Corp. (CSE:FFNT) Shares A 33% Hiding
Aug 15
Market Cool On 4Front Ventures Corp.'s (CSE:FFNT) Revenues Pushing Shares 34% Lower
Feb 16Little Excitement Around 4Front Ventures Corp.'s (CSE:FFNT) Earnings As Shares Take 28% Pounding
Jun 13Health Check: How Prudently Does 4Front Ventures (CSE:FFNT) Use Debt?
Jun 07Is 4Front Ventures (CSE:FFNT) Using Too Much Debt?
Jan 084Front Ventures (CSE:FFNT) Is Making Moderate Use Of Debt
Sep 08Shareholder Returns
| FFNT | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 14.3% | -6.0% | 0.9% |
| 1Y | -36.0% | 37.6% | 15.8% |
Return vs Industry: FFNT underperformed the Canadian Pharmaceuticals industry which returned 37.6% over the past year.
Return vs Market: FFNT underperformed the Canadian Market which returned 15.8% over the past year.
Price Volatility
| FFNT volatility | |
|---|---|
| FFNT Average Weekly Movement | 26.7% |
| Pharmaceuticals Industry Average Movement | 10.3% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in CA Market | 16.6% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: FFNT's share price has been volatile over the past 3 months.
Volatility Over Time: FFNT's weekly volatility (27%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 387 | Andrew Thut | 4frontventures.com |
4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services.
4Front Ventures Corp. Fundamentals Summary
| FFNT fundamental statistics | |
|---|---|
| Market cap | CA$73.22m |
| Earnings (TTM) | -CA$74.55m |
| Revenue (TTM) | CA$110.09m |
0.7x
P/S Ratio-1.0x
P/E RatioIs FFNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FFNT income statement (TTM) | |
|---|---|
| Revenue | US$81.48m |
| Cost of Revenue | US$48.97m |
| Gross Profit | US$32.51m |
| Other Expenses | US$87.69m |
| Earnings | -US$55.18m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 39.90% |
| Net Profit Margin | -67.72% |
| Debt/Equity Ratio | -187.2% |
How did FFNT perform over the long term?
See historical performance and comparison